Literature DB >> 4005486

Histamine and leukotriene-independent guinea-pig anaphylactic shock unaccounted for by Paf-acether.

A Detsouli, J Lefort, B B Vargaftig.   

Abstract

Ovalbumin induced dose-dependent contractions of lung parenchyma strips from sensitized guinea-pigs, whereas Paf-acether (1-alkyl-2-acetyl-sn-glycero-3-phosphoryl choline), a potential mediator of immediate hypersensitivity, induced a single contraction, followed by specific desensitization to a second exposure. Lung strips desensitized to Paf-acether contracted to ovalbumin as did non-desensitized controls, even in the presence of inhibitors of other mediators of anaphylaxis. Contractions by Paf-acether and by ovalbumin were reduced by nordihydroguaiaretic acid (NDGA) and by the phospholipase A2 inhibitor p-bromophenacyl bromide (0.1-0.3 mM). Three other anti-lipoxygenase agents (diethylcarbamazine, 5 mM; eicosatetraynoic acid and BW755c, 0.1 mM), reduced the contractions by ovalbumin but also those due to acetylcholine, indicating non-specific effects. Neither the anti-allergic compound sodium cromoglycate (3 mM) nor the anti-leukotriene agent, FPL 55712 (0.01 mM), inhibited the contractions by ovalbumin or by Paf-acether. A sensitized strip stimulated with ovalbumin released substances which contracted a non-sensitized strip mounted in the same organ bath. The contractions of the non-sensitized strip were abolished by FPL 55712 (0.01 mM), by NDGA and BW755c, (0.1 mM), whereas those of the sensitized one were unaffected. Leukotrienes are formed by the lung strips during shock but alone, they do not explain the contractile activity. The intravenous administration of ovalbumin (1 mg kg-1) led to bronchoconstriction and thrombocytopenia, which were not modified by the anti-leukotriene substance FPL 55712 nor by aspirin. Bronchoconstriction was suppressed if FPL 55712 was used in combination with aspirin (20 mg kg-1), mepyramine and methysergide (200 micrograms kg-1 of either). Pretreatment of the guinea-pigs with propranolol reduced this inhibition to approximately 60%. In no instance was thrombocytopenia prevented. In vitro contractions of the actively sensitized lung strip are not fully accounted for by histamine, FPL 55712-inhibitable leukotrienes or Paf-acether, whereas in systemic anaphylaxis histamine and leukotrienes (inhibited respectively by mepyramine and by FPL 55712) have a significant role.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4005486      PMCID: PMC1987052          DOI: 10.1111/j.1476-5381.1985.tb17374.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Bronchial asthma: the possible role of the chemical mediators of immediate hypersensitivity in the pathogenesis of subacute chronic disease.

Authors:  K F Austen; R P Orange
Journal:  Am Rev Respir Dis       Date:  1975-09

2.  Release of additional factors in anaphylaxis and its antagonism by anti-inflammatory drugs.

Authors:  P J Piper; J R Vane
Journal:  Nature       Date:  1969-07-05       Impact factor: 49.962

3.  Humoral factors affecting pulmonary inflation during acute anaphylaxis in the guinea-pig in vivo.

Authors:  H O Collier; G W James
Journal:  Br J Pharmacol Chemother       Date:  1967-06

4.  Selective inhibitor of slow reacting substance of anaphylaxis.

Authors:  J Augstein; J B Farmer; T B Lee; P Sheard; M L Tattersall
Journal:  Nat New Biol       Date:  1973-10-17

5.  Mediators of arachidonic acid-induced contractions of indomethacin-treated guinea-pig airways: leukotrienes C4 and D4.

Authors:  J F Burka; M H Saad
Journal:  Br J Pharmacol       Date:  1984-03       Impact factor: 8.739

6.  The platelet-independent release of thromboxane A2 by Paf-acether from guinea-pig lungs involves mechanisms distinct from those for leukotriene.

Authors:  J Lefort; D Rotilio; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1984-07       Impact factor: 8.739

7.  Analgesic antipyretic drugs as antagonists of bradykinin.

Authors:  H O COLLIER; P G SHORLEY
Journal:  Br J Pharmacol Chemother       Date:  1960-12

8.  Alteration of drug responsiveness in guinea-pig lung anaphylaxis using different antigen challenge concentrations.

Authors:  A J Lewis; A Blumenthal; A Dervinis
Journal:  Agents Actions       Date:  1983-06

9.  Inflammatory actions of platelet activating factor (Pafacether) in guinea-pig skin.

Authors:  J Morley; C P Page; W Paul
Journal:  Br J Pharmacol       Date:  1983-11       Impact factor: 8.739

10.  Pharmacological alteration of antigen-induced contraction of lung parenchymal strips isolated from the actively sensitized guinea pig.

Authors:  V Songsiridej; W W Busse; C K Buckner
Journal:  Eur J Pharmacol       Date:  1983-09-02       Impact factor: 4.432

View more
  10 in total

1.  Suppression of PAF-induced bronchoconstriction in the guinea-pig by oxatomide: mechanism of action.

Authors:  F P Nijkamp; G Folkerts; J R Beetens; F De Clerck
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-07       Impact factor: 3.000

2.  Blockade by methylation inhibitors of the anaphylactic response of guinea-pig lung strips.

Authors:  J Randon; J Lefort; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1987-11       Impact factor: 8.739

3.  Proceedings of the British Pharmacological Society. 10th-18th September 1986. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1986-12       Impact factor: 8.739

4.  Effect of intragastric pH on mucosal protective action of sucralfate.

Authors:  J Z Danesh; A Duncan; R I Russell; G Mitchell
Journal:  Gut       Date:  1988-10       Impact factor: 23.059

5.  Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection.

Authors:  S Desquand; J Lefort; C Dumarey; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1991-03       Impact factor: 8.739

6.  Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.

Authors:  M A Martins; P M Silva; H C Faria Neto; P T Bozza; P M Dias; M C Lima; R S Cordeiro; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

7.  Effects of REV 5901, a 5-lipoxygenase inhibitor and leukotriene antagonist, on pulmonary responses to platelet activating factor in the guinea-pig.

Authors:  G Anderson; M Fennessy
Journal:  Br J Pharmacol       Date:  1988-08       Impact factor: 8.739

8.  Platelet-activating factor-induced contraction of guinea-pig lung parenchymal strips: possible involvement of arachidonate metabolites.

Authors:  M Del Monte; A Subissi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-10       Impact factor: 3.000

9.  Interference of the Paf antagonist Ro 19-3704 with Paf and antigen-induced bronchoconstriction in the guinea-pig.

Authors:  V Lagente; S Desquand; P Hadvary; M Cirino; A Lellouch-Tubiana; J Lefort; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

10.  The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.

Authors:  S Desquand; J Lefort; C Dumarey; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1990-06       Impact factor: 8.739

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.